{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:32:59Z","timestamp":1789831979869,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jneuroim.2007.11.017","type":"journal-article","created":{"date-parts":[[2008,2,22]],"date-time":"2008-02-22T11:46:19Z","timestamp":1203680779000},"page":"181-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Subclass IgG to motor gangliosides related to infection and clinical course in Guillain\u2013Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"194","author":[{"given":"Bart C.","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"van Rijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Geleijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh J.","family":"Willison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2007.11.017_bib1","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1212\/WNL.53.9.2122","article-title":"Rapidly progressive, predominantly motor Guillain\u2013Barr\u00e9 syndrome with anti-GalNAc-GD1a antibodies","volume":"53","author":"Ang","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0165-5728(02)00209-6","article-title":"Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain\u2013Barr\u00e9 syndrome","volume":"130","author":"Ang","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1432-1033.1995.0570d.x","article-title":"Chemical structures of the core region of Campylobacter jejuni O:3 lipopolysaccharide and an associated polysaccharide","volume":"231","author":"Aspinall","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib4","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1128\/IAI.69.2.996-1001.2001","article-title":"Familial correlation of immunoglobulin G subclass responses to Plasmodium falciparum antigens in Burkina Faso","volume":"69","author":"Aucan","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jneuroim.2005.04.011","article-title":"Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire","volume":"165","author":"Boffey","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"suppl 1","key":"10.1016\/j.jneuroim.2007.11.017_bib6","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1093\/infdis\/165-Supplement_1-S167","article-title":"Humoral immune response patterns of human mucosae: induction and relation to bacterial respiratory tract infections","volume":"165","author":"Brandtzaeg","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF01954093","article-title":"Guillain\u2013Barr\u00e9 syndrome following immunisation with Haemophilus influenzae type b conjugate vaccine","volume":"152","author":"Gervaix","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1128\/IAI.72.2.1162-1165.2004","article-title":"Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain\u2013Barr\u00e9 syndrome, by horizontal exchange","volume":"72","author":"Gilbert","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ana.410440512","article-title":"Electrophysiological classification of Guillain\u2013Barr\u00e9 syndrome: clinical associations and outcome","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1212\/WNL.56.6.758","article-title":"Preceding infections, immune factors, and outcome in Guillain\u2013Barr\u00e9 syndrome","volume":"56","author":"Hadden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain\u2013Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1046\/j.1365-2958.1999.01509.x","article-title":"Sialic acid in the lipopolysaccharide of Haemophilus influenzae: strain distribution, influence on serum resistance and structural characterization","volume":"33","author":"Hood","year":"1999","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib13","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1021\/bi700685s","article-title":"A Haemophilus influenzae strain associated with Fisher syndrome expresses a novel disialylated ganglioside mimic","volume":"46","author":"Houliston","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.410400209","article-title":"Campylobacter jejuni infections and anti-GM1 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"40","author":"Jacobs","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.62.6.641","article-title":"Cytomegalovirus infections and anti-GM2 antibodies in Guillain\u2013Barr\u00e9 syndrome","volume":"62","author":"Jacobs","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/infdis\/175.3.729","article-title":"Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain\u2013Barr\u00e9 or Miller Fisher syndrome","volume":"175","author":"Jacobs","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barr\u00e9 syndrome: a case-control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jneuroim.2003.12.011","article-title":"Haemophilus influenzae as a possible cause of Guillain\u2013Barr\u00e9 syndrome","volume":"149","author":"Ju","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib19","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-5728(97)00168-9","article-title":"Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain\u2013Barr\u00e9 and Fisher's syndromes","volume":"81","author":"Koga","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib20","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1212\/WNL.57.4.686","article-title":"Miller Fisher syndrome and Haemophilus influenzae infection","volume":"57","author":"Koga","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib21","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1212\/01.WNL.0000061615.77865.83","article-title":"Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain\u2013Barr\u00e9 syndrome","volume":"60","author":"Koga","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib22","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/jnnp.2005.065359","article-title":"Ambiguous value of Haemophilus influenzae isolation in Guillain\u2013Barr\u00e9 and Fisher syndromes","volume":"76","author":"Koga","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib23","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.57.4.736","article-title":"Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry","volume":"57","author":"Kusunoki","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/WNL.51.6.1656","article-title":"Two patterns of clinical recovery in Guillain\u2013Barr\u00e9 syndrome with IgG anti-GM1 antibody","volume":"51","author":"Kuwabara","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/jnnp.70.4.560","article-title":"Indicators of rapid clinical recovery in Guillain\u2013Barre syndrome","volume":"70","author":"Kuwabara","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM195607122550201","article-title":"An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia)","volume":"255","author":"Miller Fisher","year":"1956","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib27","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/WNL.52.6.1282","article-title":"Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain\u2013Barr\u00e9 syndrome","volume":"52","author":"Mori","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib28","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/123.10.2171","article-title":"Haemophilus influenzae infection and Guillain\u2013Barr\u00e9 syndrome","volume":"123","author":"Mori","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O","article-title":"Axonal Guillain\u2013Barr\u00e9 syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan","volume":"48","author":"Ogawara","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-510X(03)00013-3","article-title":"Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection","volume":"210","author":"Ogawara","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib31","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.4049\/jimmunol.167.9.5067","article-title":"Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo","volume":"167","author":"Pulendran","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib32","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1128\/IAI.67.5.2414-2420.1999","article-title":"Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection","volume":"67","author":"Schwerer","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000115123.42929.FD","article-title":"Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry","volume":"62","author":"Susuki","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/00222615-18-1-1","article-title":"The pathogenesis of Haemophilus infection","volume":"18","author":"Turck","year":"1984","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0167-5699(93)90166-I","article-title":"Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications","volume":"14","author":"van de Winkel","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0140-6736(03)15324-X","article-title":"Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome: randomised trial","volume":"363","author":"van Koningsveld","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib37","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A clinical prognostic scoring system for Guillain\u2013Barr\u00e9 syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/brain\/118.4.841","article-title":"Guillain\u2013Barr\u00e9 syndrome without sensory loss (acute motor neuropathy)","volume":"118","author":"Visser","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib39","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2007.11.017_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-510X(97)00174-3","article-title":"Acute cytomegalovirus infection and IgM anti-GM2 antibody","volume":"154","author":"Yuki","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2007.11.017_bib41","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain\u2013Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572807004353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:12:23Z","timestamp":1759047143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572807004353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":41,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0165572807004353"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.017","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclass IgG to motor gangliosides related to infection and clinical course in Guillain\u2013Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}